Comparative cardiovascular effects of SNP, ATP and phentolamine during norepinephrine-induced hypertension in dogs
- PMID: 15278610
- DOI: 10.1007/s0054010050396
Comparative cardiovascular effects of SNP, ATP and phentolamine during norepinephrine-induced hypertension in dogs
Abstract
There has been no study comparing the advantage and disadvantage of various antihypertensive agents during surgery for pheochromocytomas because the study is difficult in clinical setting. In the present experiments using dogs, after increasing the arterial blood pressure with norepinephrine, we decreased it to the baseline with sodium nitroprusside (SNP), adenosine triphosphate (ATP), or phentolamine (PE) and compared the hemodynamic changes. A hyperdynamic state was found with ATP and with PE, but not with SNP. The norepinephrine-induced pulmonary hypertension could be successfully treated with SNP, but not with ATP or PE. The reason for these differences are thought to be the different vasodilative properties on peripheral arteries and veins. We conclude that agents that dilates the arteries and veins should be used to regulate the arterial pressure during surgical removal of a pheochromocytoma.
Similar articles
-
Cardiovascular function during controlled hypotension induced by adenosine triphosphate or sodium nitroprusside in the anesthetized dog.Anesth Analg. 1987 Feb;66(2):103-10. Anesth Analg. 1987. PMID: 3813054
-
Central versus peripheral blood pressure in malignant hypertension; effects of antihypertensive treatment.Am J Hypertens. 2013 Apr;26(4):574-9. doi: 10.1093/ajh/hps075. Epub 2013 Jan 10. Am J Hypertens. 2013. PMID: 23467212
-
Influence of tumor size on anesthetic management for pheochromocytoma resection.J Anesth. 1994 Dec;8(4):425-428. doi: 10.1007/BF02514621. J Anesth. 1994. PMID: 28921350
-
Hypotensive effects of adenosine and adenosine triphosphate compared with sodium nitroprusside.Anesth Analg. 1982 Mar;61(3):273-8. Anesth Analg. 1982. PMID: 7199840
-
Clevidipine: a review of its use in the management of acute hypertension.Am J Cardiovasc Drugs. 2009;9(2):117-34. doi: 10.2165/00129784-200909020-00006. Am J Cardiovasc Drugs. 2009. PMID: 19331440 Review.